Analysts expect the Boston, Massachusetts-based company to report quarterly earnings at $4.02 per share, down from $4.20 per share in the year-ago period. Vertex Pharmaceuticals projects quarterly ...

By Rick Winterson  Vertex Pharmaceuticals is a worldwide biotechnology corporation. It was founded 35 years ago in Cambridge.  It has now established its global headquarters on Fan Pier in South ...

The Boston area began 2025 with a record-high office vacancy rate of 17%. Yet there are at least seven notable office ...

IT firm cb20 is expanding its services and reach into Boston. The Saratoga Springs, New York company is planning an office there later this year, Chris Pickett, president and CEO, said.

The computer firm’s hybrid and remote workers — including those based out of the Hopkinton and Franklin offices — are expected to return to the office for five days a week next month, according to a ...

A logistics center in Uxbridge has sold for $120 million to Boston private equity real estate firm Rockpoint, making it the ...

HAPPY BIRTHDAY — to David Edelman, Ropes & Gray’s Abby Cable; former Gov. Charlie Baker senior adviser and the NCAA’s Tim ...

Rep. Gabe Amo (D-R.I.) on Sunday criticized President Trump for tying diversity, equity and inclusion (DEI) hiring practices ...

County health officials are warning of a possible tuberculosis exposure for students, employees and others who may have ...

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...

Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years ...

The drug represents a new pathway to treating people with pain due to surgeries or traumatic injuries, avoiding the addictive risks of opioids.